These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 5818927)
41. [An experimental study of the therapeutic effect of interleukin-2 and interleukin-12 with and without amphotericin B on pulmonary fungal infection]. Zhang CR; Tang YC; Kawakami K; Zhang TT; Zhang KX; Zhu JX Zhonghua Jie He He Hu Xi Za Zhi; 2004 Apr; 27(4):234-6. PubMed ID: 15144612 [TBL] [Abstract][Full Text] [Related]
42. Recovery from pulmonary mucormycosis and candidiasis in diabetic ketoacidosis. Passi GR; Menon PS; Gupta DK; Lodha R Indian Pediatr; 1996 Dec; 33(12):1047-50. PubMed ID: 9141809 [No Abstract] [Full Text] [Related]
44. [On the therapy of generalized candidiasis of both lungs]. Lampe W Med Welt; 1967 Feb; 5():282-6. PubMed ID: 5595146 [No Abstract] [Full Text] [Related]
45. Aureobasidium pullulans infection: fungemia in an infant and a review of human cases. Hawkes M; Rennie R; Sand C; Vaudry W Diagn Microbiol Infect Dis; 2005 Mar; 51(3):209-13. PubMed ID: 15766608 [No Abstract] [Full Text] [Related]
46. Quiz page. Invasive pulmonary aspergillosis presenting with a pulmonary nodule, pneumomediastinum, pneumothorax, and pneumopericardium. Sengul S; Keven K; Kutlay S; Ergun I; Azap A; Erbay B Am J Kidney Dis; 2004 Oct; 44(4):A47, E47-9. PubMed ID: 15384032 [No Abstract] [Full Text] [Related]
47. Part XIII. Systemic antifungal therapy. Busse KH; Gentry CA; Bronze MS; Greenfield RA J Okla State Med Assoc; 2007 Sep; 100(9):344-51. PubMed ID: 18020039 [TBL] [Abstract][Full Text] [Related]
48. [Mycosis of the feet: therapy]. Beurey J; Weber M; Mougeolle JM Phlebologie; 1969; 22(1):83-90. PubMed ID: 5775651 [No Abstract] [Full Text] [Related]
49. [Choice and use of antifungal drugs]. Dupont B Rev Prat; 2001 Apr; 51(7):752-7. PubMed ID: 11387672 [TBL] [Abstract][Full Text] [Related]
50. Lipid-based amphotericin in pulmonary zygomycosis: safety and efficacy of high exposure in a renal allograft recipient. Crompton JA; Alexander D; Somerville T; Shihab FS Transpl Infect Dis; 2004 Dec; 6(4):183-7. PubMed ID: 15762937 [TBL] [Abstract][Full Text] [Related]
51. Adjuvant intrapleural amphotericin B therapy for pulmonary mucormycosis in a cardiac allograft recipient. Kfoury AG; Smith JC; Farhoud HH; Terreros DA; Stringham JC; Taylor DO; Renlund DG Clin Transplant; 1997 Dec; 11(6):608-12. PubMed ID: 9408694 [TBL] [Abstract][Full Text] [Related]
52. AmBisome treatment of pulmonary aspergillosis in a patient with tuberculosis. Viggiani P; Besozzi G Acta Biomed; 2006; 77 Suppl 4():31-3. PubMed ID: 17370569 [TBL] [Abstract][Full Text] [Related]
53. Aerosolized antifungal prophylaxis: the winds of change? Perfect JR Clin Infect Dis; 2008 May; 46(9):1409-11. PubMed ID: 18419444 [No Abstract] [Full Text] [Related]
54. [Prevention of mucositis]. Priour A Soins Pediatr Pueric; 1995; (166):32-3. PubMed ID: 8681244 [No Abstract] [Full Text] [Related]